Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Radient Technologies Inc V.RTI.H

Alternate Symbol(s):  RDDTF

Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles.


TSXV:RTI.H - Post by User

Bullboard Posts
Post by good2004on Oct 03, 2017 11:05am
122 Views
Post# 26770490

FDA 's new comprehensive plan for Nicotine regulation

FDA 's new comprehensive plan for Nicotine regulation
Excerpt of news release of another stock regarding Nicotine regulation. https://www.stockwatch.com/News/Item.aspx?bid=U-b005925-U%3aXXII-20171003&symbol=XXII®ion=U 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is focused on tobacco harm reduction, announced today that the Vermont Center on Behavior and Healths 5th Annual Conference will focus on Tobacco Regulatory Science and will include the prodigious science surrounding 22nd Centurys Very Low Nicotine tobacco cigarettes. This national conference will take place on October 5-6, 2017 in Burlington, Vermont and will feature, as its keynote speaker, Mitch Zeller, J.D., Director of the U.S. Food and Drug Administration Center for Tobacco Products. Director Zellers address comes on the heels of FDA Commissioner Dr. Scott Gottliebs July 28th announcement that the FDA is planning to reduce nicotine content in cigarettes to non-addictive levels. In his address to open the conference, Director Zeller will expand upon FDAs New Comprehensive Plan for Nicotine Regulation. This Tobacco Regulatory Science conference gathers together many of the worlds foremost scientific experts on the important behavioral impacts of Very Low Nicotine tobacco cigarettes. Chairing the panel on Very Low Nicotine Content Cigarettes is Neal Benowitz, M.D., Core Director and Investigator, University of California, San Francisco (UCSF) Tobacco Center of Regulatory Science. Dr. Benowitz recently authored a paper: Comprehensive Nicotine Regulation to End the Combustible Tobacco Epidemic where he states that an FDA-mandated 95% reduction in nicotine content would make it impossible to compensate by smoking cigarettes more intensively or smoking more per day.
Bullboard Posts